Interestingly, previous studies in our lab had found that NAP1L1 is a potential candidate of HDGF interaction proteins in endometrial carcinoma using exogenous Co-IP assay combined with mass spectrometry (unpublished data). This evidence concerns the gene NAP1L1 and endometrial carcinoma.